COVID-19 Infection and Multiple Myeloma

NCT04492371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1054

Last updated 2024-03-05

No results posted yet for this study

Summary

Collect in an observational study the outcomes of COVID19 infection in MM patients across Europe.

Conditions

Sponsors & Collaborators

  • Fondazione EMN Italy Onlus

    collaborator OTHER
  • Stichting European Myeloma Network

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2022-08-18
Completion
2024-03-01

Countries

  • Austria
  • Belgium
  • Czechia
  • Germany
  • Greece
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492371 on ClinicalTrials.gov